BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CEM Corporation Introduces New Breakthrough Technology for Microwave Peptide Synthesis


6/25/2013 9:23:47 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MATTHEWS, N.C., June 24, 2013 /PRNewswire/ -- CEM Corporation, a leading global provider of microwave laboratory instrumentation is pleased to announce the introduction of a new family of products that significantly alters the paradigm of peptide synthesis from early discovery through pre-clinical studies. The Liberty Blue line of research scale microwave peptide synthesizers and the Liberty XL mid-scale microwave peptide synthesizer were given an enthusiastic reception by attendees of the 23rd American Peptide Symposium in Waikoloa, Hawaii on Sunday, June 23rd.

(Photo: http://photos.prnewswire.com/prnh/20130623/CL33755)
(Logo: http://photos.prnewswire.com/prnh/20090622/CL35336LOGO-b)

The Liberty Blue technology allows for 4-minute cycle times and a 90% reduction in solvent usage compared to existing methods for making peptides. The technology represents significant advances in hardware design, as well as remarkable improvements to the chemistry, resulting in greater speed and flexibility, better peptide purities and yields, and improved reliability.

"This is transformational technology that will dramatically change the world of peptide synthesis," said Michael J. Collins, president and CEO of CEM Corporation, "It will provide the unprecedented ability to run the gamut of peptide synthesis from generating milligram amounts for lead optimization to building targeted libraries of peptides to producing 200-gram quantities for pre-clinical studies."

"Cycle times are 10 times faster than current microwave synthesizers, allowing chemists to make a normal peptide in less than an hour. In addition, even with the fast cycle times, these new microwave peptide synthesizers produce peptides in unparalleled purities," Collins continued.

The systems' patent-pending Flex-Add Technology provides infinite volume delivery with a high degree of accuracy and precision, allowing the Liberty Blue line coverage of a wide scale range from 0.025 to 5 mmol, the broadest range of any line of research scale microwave peptide synthesizers. In addition, the chemistry is directly scalable up to 100 mmol with the new Liberty XL.

Designed for maximum speed, efficiency, and ease-of-use, the Liberty Blue line of microwave peptide synthesizers consists of manual, automated, and high-throughput systems, while the Liberty XL is an automated mid-scale system. The systems feature CEM's patented technology for using microwave energy for both the coupling and deprotection steps of the synthesis, ensuring higher purities and yields faster than ever before.

"We expect Liberty Blue and Liberty XL to have an even greater impact on peptide synthesis than the introduction of our original microwave peptide technology, which has become the method of choice for many researchers. These new products will give chemists the opportunity to once again push the boundaries of peptide synthesis," concluded Collins.

CEM Corporation, a private company based in Matthews, North Carolina, is the leading global company specializing in scientific solutions for critical laboratory applications. The Company has subsidiaries in the United Kingdom& Ireland, Germany, Italy, France, and Japan, as well as a global network of distributors. CEM designs and manufactures systems for bioscience applications, life sciences, analytical laboratories and processing plants worldwide. The Company's products are used in many industries including pharmaceutical, biotech, chemical, and food processing, as well as academic research.

SOURCE CEM Corporation



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES